Daily aspirin use has “no net benefit” for preventing cardiovascular disease, research shows

Credit: Adobe
Credit: Adobe

People 60 years old and older should not start taking daily aspirin to prevent cardiovascular disease, according to draft recommendations from a national task force that monitors best ways to prevent disease.

The U.S. Preventive Services Task force’s proposed guidance says daily aspirin “has no net benefit” for cardiovascular health.

The task force also says people age 40 to 59 with higher risk of disease should make individual decisions about whether to take aspirin.

“Persons who are not at increased risk for bleeding and are willing to take low-dose aspirin daily are more likely to benefit,” the task force said.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Besides the new proposed recommendations for preventing cardiovascular disease, they also changed the previous recommendation for colorectal cancer.

The task force “concluded that the evidence is inadequate that low-dose aspirin use reduces (colorectal cancer) incidence or mortality.”

This is an excerpt. Read the original post here. 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.